MAPK3 and liver cancer: In the late stage of liver cancer, it can inhibit the proliferation and spread of cancer cells by modulating the hTERT, MEK1/ERK1/2, Notch, and Wnt/β-catenin related signaling pathways (Zhao et al., 2021).